Published in J Oncol Pract on March 06, 2012
Is race/ethnicity related to the presence or severity of pain in colorectal and lung cancer? J Pain Symptom Manage (2014) 0.86
Screening for Pain in the Ambulatory Cancer Setting: Is 0-10 Enough? J Oncol Pract (2015) 0.75
Unresolved Pain Interference among Colorectal Cancer Survivors: Implications for Patient Care and Outcomes. Pain Med (2015) 0.75
Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med (2010) 29.06
Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54
Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA (1998) 6.88
Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol (2007) 6.35
The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Med (2003) 4.56
Pain and treatment of pain in minority patients with cancer. The Eastern Cooperative Oncology Group Minority Outpatient Pain Study. Ann Intern Med (1997) 3.48
Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol (2009) 2.52
Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manage (1990) 2.48
High prevalence of pain in patients with cancer in a large population-based study in The Netherlands. Pain (2007) 2.29
The prevalence and severity of pain in cancer. Cancer (1982) 2.07
Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group. J Pain Symptom Manage (1996) 1.82
Multicentre study of cancer pain and its treatment in France. BMJ (1995) 1.78
Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment. Cancer (2000) 1.67
Cancer pain and psychosocial factors: a critical review of the literature. J Pain Symptom Manage (2002) 1.56
Race, ethnicity, and pain treatment: striving to understand the causes and solutions to the disparities in pain treatment. J Law Med Ethics (2001) 1.47
Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control. Cancer (2002) 1.46
The epidemiology of cancer pain. Cancer Invest (2005) 1.42
Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain (1996) 1.37
The prevalence of pain in four cancers. Cancer (1987) 1.25
Gender differences in pain, fatigue, and depression in patients with cancer. J Natl Cancer Inst Monogr (2004) 1.21
A multicenter evaluation of cancer pain control by palliative care teams. J Pain Symptom Manage (1997) 1.20
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer. Br J Cancer (2004) 1.20
Prevalence and management of cancer pain in South Africa. Pain (2001) 1.17
Self-reported prevalence, etiology, and characteristics of pain in oncology outpatients. Eur J Pain (2007) 1.16
Consistent and breakthrough pain in diverse advanced cancer patients: a longitudinal examination. J Pain Symptom Manage (2008) 1.03
No evidence for sex differences in the severity and treatment of cancer pain. J Pain Symptom Manage (2004) 0.98
Pain, opioid use, and survival in hospitalized patients with advanced cancer. J Clin Oncol (1992) 0.97
Ethnic differences in pain among outpatients with terminal and end-stage chronic illness. Pain Med (2005) 0.96
Psychological distress of patients with advanced cancer: influence and contribution of pain severity and pain interference. Cancer Nurs (2006) 0.96
Disparities between black and white patients with cancer pain: the effect of perception of control over pain. Pain Med (2005) 0.94
Prevalence and correlates of pain in the Canadian National Palliative Care Survey. Pain Res Manag (2009) 0.94
Symptom distress in patients attending an outpatient palliative radiotherapy clinic. J Pain Symptom Manage (2005) 0.92
The impact of demographic and disease-specific variables on pain in cancer patients. J Pain Symptom Manage (2003) 0.91
Racial differences in pain during 1 year among women with metastatic breast cancer: a hazards analysis of interval-censored data. Cancer (2008) 0.91
The incidence of cancer pain and improvement of pain management in Japan. Postgrad Med J (1991) 0.88
Pain and its treatment in patients with cancer in Korea. Oncology (2003) 0.86
Cancer-related pain--I. Prevalence in an outpatient setting as a function of stage of disease and type of cancer. J Psychosom Res (1984) 0.83
Adverse drug events in ambulatory care. N Engl J Med (2003) 13.38
Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol (2004) 7.45
Heavy metal content of ayurvedic herbal medicine products. JAMA (2004) 7.33
Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2004) 7.02
Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med (2003) 7.01
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ (2008) 6.97
Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med (2005) 6.27
Intermittent versus continuous androgen deprivation in prostate cancer. N Engl J Med (2013) 6.17
Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA (2008) 5.72
Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol (2008) 5.61
Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation (2006) 5.47
Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet (2004) 4.99
Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol (2003) 4.50
Worsening trends in the management and treatment of back pain. JAMA Intern Med (2013) 4.49
Overrides of medication alerts in ambulatory care. Arch Intern Med (2009) 4.24
Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol (2003) 4.24
Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study. BMJ (2014) 3.90
Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. J Gen Intern Med (2003) 3.69
Sham device v inert pill: randomised controlled trial of two placebo treatments. BMJ (2006) 3.31
Characteristics of visits to licensed acupuncturists, chiropractors, massage therapists, and naturopathic physicians. J Am Board Fam Pract (2002) 3.26
Electronic medical record reminders and panel management to improve primary care of elderly patients. Arch Intern Med (2011) 3.22
Hospice use among Medicare managed care and fee-for-service patients dying with cancer. JAMA (2003) 3.19
Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions. J Natl Cancer Inst (2012) 3.16
Linguistic and cultural barriers to care. J Gen Intern Med (2003) 3.15
Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol (2002) 3.09
End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol (2010) 2.97
Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA (2010) 2.93
Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. J Clin Oncol (2013) 2.91
Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol (2011) 2.83
HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis. J Clin Oncol (2004) 2.78
Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care (2005) 2.75
Should the hemoglobin A1c diagnostic cutoff differ between blacks and whites? A cross-sectional study. Ann Intern Med (2012) 2.75
Views of American oncologists about the purposes of clinical trials. J Natl Cancer Inst (2002) 2.71
American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol (2008) 2.69
Outpatient prescribing errors and the impact of computerized prescribing. J Gen Intern Med (2005) 2.64
Physicians' attitudes about multiplex tumor genomic testing. J Clin Oncol (2014) 2.62
Tai chi exercise in patients with chronic heart failure: a randomized clinical trial. Arch Intern Med (2011) 2.60
Preferences for cardiopulmonary resuscitation among patients 80 years or older: the views of patients and their physicians. J Am Med Dir Assoc (2003) 2.59
Use of complementary and alternative medical therapies among racial and ethnic minority adults: results from the 2002 National Health Interview Survey. J Natl Med Assoc (2005) 2.56
Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer. JAMA (2012) 2.56
Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis. J Natl Cancer Inst (2008) 2.56
Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer. J Clin Oncol (2012) 2.53
Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis. J Clin Oncol (2005) 2.52
Effects of tai chi mind-body movement therapy on functional status and exercise capacity in patients with chronic heart failure: a randomized controlled trial. Am J Med (2004) 2.50
Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730). J Clin Oncol (2005) 2.48
Patterns and perceptions of care for treatment of back and neck pain: results of a national survey. Spine (Phila Pa 1976) (2003) 2.47
What can hospitalized patients tell us about adverse events? Learning from patient-reported incidents. J Gen Intern Med (2005) 2.46
Differences between early and late readmissions among patients: a cohort study. Ann Intern Med (2015) 2.41
A treatment trial of acupuncture in IBS patients. Am J Gastroenterol (2009) 2.41
Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology (2008) 2.37
Racial differences in predictors of intensive end-of-life care in patients with advanced cancer. J Clin Oncol (2009) 2.36
Mentoring in medicine: keys to satisfaction. Am J Med (2002) 2.36
Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Inst (2006) 2.34
Personality disorders in the oncology setting. J Support Oncol (2011) 2.33
Using a multihospital survey to examine the safety culture. Jt Comm J Qual Saf (2004) 2.29
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol (2006) 2.29
A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network. Ann Surg (2006) 2.29
Insurance coverage, medical conditions, and visits to alternative medicine providers: results of a national survey. Arch Intern Med (2002) 2.27
Prevalence and patterns of adult yoga use in the United States: results of a national survey. Altern Ther Health Med (2004) 2.26
A comparison of outcomes resulting from generalist vs specialist care for a single discrete medical condition: a systematic review and methodologic critique. Arch Intern Med (2007) 2.24
Representativeness of participants in the cancer care outcomes research and surveillance consortium relative to the surveillance, epidemiology, and end results program. Med Care (2013) 2.22
External validation of an index to predict up to 9-year mortality of community-dwelling adults aged 65 and older. J Am Geriatr Soc (2011) 2.20
Patients' experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2010) 2.16
Index to predict 5-year mortality of community-dwelling adults aged 65 and older using data from the National Health Interview Survey. J Gen Intern Med (2009) 2.15
Parents' views of cancer-directed therapy for children with no realistic chance for cure. J Clin Oncol (2008) 2.12
Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst (2003) 2.11
End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med (2012) 2.08
Comparing patient-reported hospital adverse events with medical record review: do patients know something that hospitals do not? Ann Intern Med (2008) 2.06
Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol (2006) 2.06
An empirical model to estimate the potential impact of medication safety alerts on patient safety, health care utilization, and cost in ambulatory care. Arch Intern Med (2009) 2.01
Screening for statin-related toxicity: the yield of transaminase and creatine kinase measurements in a primary care setting. Arch Intern Med (2003) 1.98
Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol (2012) 1.95
Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol (2009) 1.94
Treatment decision making in early-stage breast cancer: should surgeons match patients' desired level of involvement? J Clin Oncol (2002) 1.89
Prediction of 6-month survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility guidelines. JAMA (2010) 1.87
Medication errors in the home: a multisite study of children with cancer. Pediatrics (2013) 1.87
Site of oncologic specialty care for older adolescents in Utah. J Clin Oncol (2007) 1.87
Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles? J Clin Oncol (2010) 1.84
Mentoring matters. Mentoring and career preparation in internal medicine residency training. J Gen Intern Med (2006) 1.83
Addition of choice of complementary therapies to usual care for acute low back pain: a randomized controlled trial. Spine (Phila Pa 1976) (2007) 1.80
Determinants of medical students' perceived preparation to perform end-of-life care, quality of end-of-life care education, and attitudes toward end-of-life care. J Palliat Med (2010) 1.79
Parent and physician perspectives on quality of care at the end of life in children with cancer. J Clin Oncol (2005) 1.78
Discussions with physicians about hospice among patients with metastatic lung cancer. Arch Intern Med (2009) 1.77
Age-specific fluoride exposure in drinking water and osteosarcoma (United States). Cancer Causes Control (2006) 1.76
Usability of a computerized PAINReportIt in the general public with pain and people with cancer pain. J Pain Symptom Manage (2003) 1.76
Complementary and alternative medical therapies for chronic low back pain: What treatments are patients willing to try? BMC Complement Altern Med (2004) 1.76
Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer (2012) 1.75
Physician-assisted death--a last resort? N Engl J Med (2002) 1.75
Hope and prognostic disclosure. J Clin Oncol (2007) 1.73
Length of stay in home care before and after the 1997 Balanced Budget Act. JAMA (2003) 1.72
Use of colony-stimulating factors with chemotherapy: opportunities for cost savings and improved outcomes. J Natl Cancer Inst (2011) 1.71
Satisfaction with quality and access to health care among people with disabling conditions. Int J Qual Health Care (2002) 1.71
Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants. J Natl Cancer Inst (2005) 1.70
Selecting high priority quality measures for breast cancer quality improvement. Med Care (2008) 1.70
Medical oncologists' perceptions of financial incentives in cancer care. J Clin Oncol (2012) 1.69
Protecting an endangered species: training physicians to conduct clinical research. Acad Med (2009) 1.66